PRESS RELEASE published on 09/08/2026 at 07:00, 1 month 27 days ago Sandoz hosts Capital Markets Day and unveils Bio100 ambition – maximising Sandoz value in its golden decade for biosimilars Sandoz hosts Capital Markets Day unveiling Bio100 ambition to maximize value in golden decade for biosimilars. Strong growth plan aims for 100+ biosimilars by 2040 Growth Strategy Biosimilars Capital Markets Day Sandoz Bio100 Ambition
BRIEF published on 08/17/2026 at 02:05, 2 months 19 days ago Sandoz et Henlius nouent une importante collaboration dans le domaine des biosimilaires Sandoz Expansion Du Marché Henlius Collaboration Sur Les Biosimilaires Pipeline Pharmaceutique
BRIEF published on 08/17/2026 at 02:05, 2 months 19 days ago Sandoz and Henlius Forge Major Biosimilar Collaboration Market Expansion Sandoz Biosimilar Collaboration Henlius Pharmaceutical Pipeline
PRESS RELEASE published on 08/17/2026 at 02:00, 2 months 19 days ago Sandoz announces strategic collaboration with Henlius on up to 10 biosimilars, further expanding industry-leading pipeline Sandoz announces strategic collaboration with Henlius on up to 10 biosimilars, expanding industry-leading pipeline. Agreement includes cetuximab, evolocumab, belimumab biosimilars, and option for human hyaluronidase Collaboration Biosimilars Pipeline Sandoz Henlius
BRIEF published on 08/05/2026 at 07:05, 3 months ago Sandoz annonce de solides résultats financiers pour le premier semestre 2026 Augmentation Des Ventes Nettes Groupe Sandoz AG Croissance Des Biosimilaires Résultats Financiers Du Premier Semestre 2026 Amélioration De L'EBITDA De Base
BRIEF published on 08/05/2026 at 07:05, 3 months ago Sandoz Reports Strong H1 2026 Financial Results Net Sales Increase Sandoz Group AG Biosimilars Growth H1 2026 Financial Results Core EBITDA Improvement
PRESS RELEASE published on 08/05/2026 at 07:00, 3 months ago Sandoz delivers strong H1 2026 results, with outstanding biosimilar growth in the second quarter Sandoz delivers strong H1 2026 results, with outstanding biosimilar growth in the second quarter. Company confirms full-year guidance amidst solid financial performance Financial Performance Guidance Sandoz H1 2026 Results Biosimilar Growth
BRIEF published on 08/03/2026 at 07:05, 3 months 2 days ago Sandoz fait des progrès dans le règlement des litiges relatifs aux médicaments génériques aux États-Unis Marché Pharmaceutique Résolution Juridique Les Colonies De Sandoz Litiges Relatifs Aux Génériques Aux États-Unis Réclamations Antitrust
BRIEF published on 08/03/2026 at 07:05, 3 months 2 days ago Sandoz Advances in Resolving US Generic Medicine Litigation Pharmaceutical Market Legal Resolution Sandoz Settlements US Generic Litigation Antitrust Claims
PRESS RELEASE published on 08/03/2026 at 07:00, 3 months 2 days ago Sandoz takes further steps to resolve legacy US generic medicine litigation Sandoz Group AG announces settlements to resolve US generic medicine litigation with 43 states & territories and indirect resellers, with no impact on financial outlook Litigation Settlements Financial Outlook Sandoz US Generic Medicine
Published on 11/05/2026 at 08:00, 1 hour 12 minutes ago Caledonia Mining Corporation Plc: Caledonia Group Signs US$150 Million Interim Financing Facilities Agreement to Support Construction of the Bilboes Gold Project
Published on 11/04/2026 at 23:10, 10 hours 2 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 10 hours 12 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 10 hours 57 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/05/2026 at 09:05, 7 minutes ago SINBON Links Executive Pay to ESG, Cuts Scope 1 and 2 Emissions 27.68% in 2025 Sustainability Report
Published on 11/05/2026 at 09:03, 8 minutes ago u-blox sets a new size benchmark for antenna-integrated GNSS with the SAM-M11N
Published on 11/05/2026 at 09:02, 10 minutes ago RHÖN-KLINIKUM AG reports results for the third quarter of 2026
Published on 11/05/2026 at 09:00, 12 minutes ago Original-Research: ZEAL Network SE (von NuWays AG): BUY
Published on 11/05/2026 at 07:00, 2 hours 12 minutes ago Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %
Published on 11/05/2026 at 07:00, 2 hours 12 minutes ago Eurazeo’s European asset management platform continues to gain momentum, driven by sustained international fundraising
Published on 11/05/2026 at 07:00, 2 hours 12 minutes ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%